Their previous guidance was that 1H18 should be similar results...

Their previous guidance was that 1H18 should be similar results to 2H17 which was roughly $9mil NPAT.
Because of the roughly $1.5 mil of bad debt write -off reductions, combined with the ongoing growth in loan books it seems like this should be achieved easily enough, if not exceeded.
The catch is that the shrinking SACC loans may have a greater weighting than the increasing MACC and other loans, as well as that managment may have already factored this into their forward estimations for 1H.

Anyway the business looks solid, which is enough to make a low PE play like CCV return higher than the average.
Whats more is that a return to growth is evidently on the horizon, which will cause a significant SP upwards adjustment whenever it finally arrives.
Until then, further sustained annual NPAT reductions appear to be increasingly unlikely.

Was anyone at the meeting?